Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | January 08, 2025 |
| PDB ID | UniProt ID | Title ▲ | Descriptor |
|---|---|---|---|
| 8V0P | P0DTC2 | SARS-CoV-2 Omicron-XBB.1.16 3-RBD down Spike Protein Trimer 2 (S-GSAS-Omicron-XBB.1.16) | |
| 8V0Q | P0DTC2 | SARS-CoV-2 Omicron-XBB.1.16 3-RBD down Spike Protein Trimer 3 (S-GSAS-Omicron-XBB.1.16) | |
| 8UIR | P0DTC2 | SARS-CoV-2 Omicron-XBB.1.16 3-RBD down Spike Protein Trimer consensus (S-GSAS-Omicron-XBB.1.16) | |
| 8V0L | P0DTC2 | SARS-CoV-2 Omicron-XBB.1.16 3-RBD-down Spike Protein Trimer 1 (S-RRAR-Omicron-XBB.1.16) | |
| 8V0M | P0DTC2 | SARS-CoV-2 Omicron-XBB.1.16 3-RBD-down Spike Protein Trimer 2 (S-RRAR-Omicron-XBB.1.16) | |
| 8V0N | P0DTC2 | SARS-CoV-2 Omicron-XBB.1.16 3-RBD-down Spike Protein Trimer 3 (S-RRAR-Omicron-XBB.1.16) | |
| 8UK1 | P0DTC2 | SARS-CoV-2 Omicron-XBB.1.16 3-RBD-down Spike Protein Trimer consensus (S-RRAR-Omicron-XBB.1.16) | |
| 8V0R | P0DTC2 | SARS-CoV-2 Omicron-XBB.1.5 3-RBD down Spike Protein Trimer 1 (S-GSAS-Omicron-XBB.1.5) | |
| 8V0S | P0DTC2 | SARS-CoV-2 Omicron-XBB.1.5 3-RBD down Spike Protein Trimer 2 (S-GSAS-Omicron-XBB.1.5) | |
| 8V0T | P0DTC2 | SARS-CoV-2 Omicron-XBB.1.5 3-RBD down Spike Protein Trimer 3 (S-GSAS-Omicron-XBB.1.5) | |
| 8V0U | P0DTC2 | SARS-CoV-2 Omicron-XBB.1.5 3-RBD down Spike Protein Trimer 4 (S-GSAS-Omicron-XBB.1.5) | |
| 8UKD | P0DTC2 | SARS-CoV-2 Omicron-XBB.1.5 3-RBD down Spike Protein Trimer consensus (S-GSAS-Omicron-XBB.1.5) | |
| 8XSE | P0DTC2 | SARS-CoV-2 RBD + IMCAS-123 + IMCAS-72 Fab | |
| 8XSE | 8XSE | SARS-CoV-2 RBD + IMCAS-123 + IMCAS-72 Fab | |
| 8XSI | P0DTC2 | SARS-CoV-2 RBD + IMCAS-364 (Local Refinement) | |
| 8XSI | 8XSI | SARS-CoV-2 RBD + IMCAS-364 (Local Refinement) | |
| 8XSF | Q9BYF1 | SARS-CoV-2 RBD + IMCAS-364 + hACE2 | |
| 8XSF | P0DTC2 | SARS-CoV-2 RBD + IMCAS-364 + hACE2 | |
| 8XSF | 8XSF | SARS-CoV-2 RBD + IMCAS-364 + hACE2 | |
| 8EL2 | P0DTC2 | SARS-CoV-2 RBD bound to neutralizing antibody Fab ICO-hu23 | |
| 8EL2 | 8EL2 | SARS-CoV-2 RBD bound to neutralizing antibody Fab ICO-hu23 | |
| 7KDG | P0DTC2 | SARS-CoV-2 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS) | |
| 7F3Q | P0DTC2 | SARS-CoV-2 RBD in complex with A5-10 Fab and A34-2 Fab | |
| 7F3Q | 7F3Q | SARS-CoV-2 RBD in complex with A5-10 Fab and A34-2 Fab | |
| 7KLG | P0DTC2 | SARS-CoV-2 RBD in complex with Fab 15033 | |
| 7KLG | 7KLG | SARS-CoV-2 RBD in complex with Fab 15033 | |
| 7KLH | P0DTC2 | SARS-CoV-2 RBD in complex with Fab 15033-7 | |
| 7KLH | 7KLH | SARS-CoV-2 RBD in complex with Fab 15033-7 | |
| 8E1G | P0DTC2 | SARS-CoV-2 RBD in complex with Omicron-neutralizing antibody 2A10 | |
| 8E1G | 8E1G | SARS-CoV-2 RBD in complex with Omicron-neutralizing antibody 2A10 | |
| 7KDH | P0DTC2 | SARS-CoV-2 RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS) | |
| 7BH9 | Q9BYF1 | SARS-CoV-2 RBD-62 in complex with ACE2 peptidase domain | |
| 7BH9 | P0DTC2 | SARS-CoV-2 RBD-62 in complex with ACE2 peptidase domain | |
| 8DCC | P0DTC2 | SARS-CoV-2 Receptor-Binding Domain SPEEDesign Immunogen 3 Bound to P2B-2F6 Fab | |
| 8DCC | 8DCC | SARS-CoV-2 Receptor-Binding Domain SPEEDesign Immunogen 3 Bound to P2B-2F6 Fab | |
| 7N8I | P0DTC2 | SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 (Local Refinement of the NTD/S2L20) | |
| 7N8I | 7N8I | SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 (Local Refinement of the NTD/S2L20) | |
| 7N8H | P0DTC2 | SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 Global Refinement | |
| 7N8H | 7N8H | SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 Global Refinement | |
| 8VYE | 8VYE | SARS-CoV-2 S (C.37 Lambda variant) plus S309, S2L20, and S2X303 Fabs | |
| 8VYE | P0DTC2 | SARS-CoV-2 S (C.37 Lambda variant) plus S309, S2L20, and S2X303 Fabs | |
| 7T67 | P0DTC2 | SARS-CoV-2 S (Spike Glycoprotein) D614G with One(1) RBD Up | |
| 7T3M | P0DTC2 | SARS-CoV-2 S (Spike Glycoprotein) D614G with Three (3) RBDs Up, Bound to Antibody 2-7 scFv, composite map | |
| 7T3M | 7T3M | SARS-CoV-2 S (Spike Glycoprotein) D614G with Three (3) RBDs Up, Bound to Antibody 2-7 scFv, composite map | |
| 9C44 | P0DTC2 | SARS-CoV-2 S + S2L20 | |
| 9C44 | 9C44 | SARS-CoV-2 S + S2L20 | |
| 9C45 | P0DTC2 | SARS-CoV-2 S + S2L20 (local refinement of NTD and S2L20 Fab variable region) | |
| 9C45 | 9C45 | SARS-CoV-2 S + S2L20 (local refinement of NTD and S2L20 Fab variable region) | |
| 7TLY | 7TLY | SARS-CoV-2 S B.1.1.529 Omicron variant (RBD + S309 Local Refinement) | |
| 7TLY | P0DTC2 | SARS-CoV-2 S B.1.1.529 Omicron variant (RBD + S309 Local Refinement) |
